Copernicus Group® (WCG) companies are united by a common element: the spirit of ingenious leadership.
|Each company in our Group is a pioneer in its specialty, having inspired new ways of thinking and operating in the clinical research industry. And each company is a proven entity, with a demonstrated track record of success. As a family of companies, we embrace change. We have the courage to invent new solutions and the strength to do what’s right. We uphold the principles of quality and integrity, and are steadfast and unwavering in support of our clients. We are audacious and bold. We are WCG.|
The first independent review board, Western Institutional Review Board® (WIRB) was founded in 1968 and remains the unrivaled leader in ethical review. Recognized as the gold standard of human subject protection, WIRB is the trusted partner to over 1,000 institutions in the United States alone, ranging from small community hospitals and research sites to large academic medical centers and universities. WIRB is also the largest global presence in the ethical review space, with a network of affiliates and fellows reviewing research around the world.
With 7 individual AAHRPP-accredited panels, over 100 experienced board members, and over 40 years of experience in protocol and study-related review, only WIRB has the capacity and expertise to provide custom solutions to meet the unique and highly-specialized needs of its institutional partners.
For more information, please visit www.wirb.com.
Copernicus Group Independent Review Board® (Copernicus IRB) was founded in 1996, on the principle that quality must never be sacrificed to speed. To maintain industry-leading turnaround times while driving a continuous cycle of quality improvement, Copernicus IRB has adopted systems and processes that drive unparalleled efficiency and compliance. In fact, Copernicus IRB was the first independent review board to achieve certification by the International Organization for Standardization (ISO), a product of its rigorous quality management systems. In 2015, Copernicus Group IRB’s sister company, WIRB, became the second IRB to receive the prestigious ISO 9001:2008 certification.
Today, Copernicus IRB is the foremost provider of high-quality ethical review services to all major sponsors, ranging from large pharmaceutical corporations and device manufacturers to small and growing biotechnology companies, as well as the leading contract research organizations (CROs). Relentless in its pursuit of efficiency, Copernicus IRB is incomparably organized to meet the demands of industry, consistently delivering the most streamlined and highest quality review services to its clients.
For more information, please visit www.cgirb.com.
In 2013, IRBNet was fully integrated with Western Institutional Review Board® (WIRB), enabling clients to enjoy unified, seamless management of both internal and external IRB submissions, in addition to Enterprise Conflict of Interest (COI), Institutional Animal Care and Use Committee (IACUC), Biosafety (IBC), Sponsored Programs, Publication Tracking, Training & Credentials Management, and other institutional research functions.
For more information, please visit www.irbnet.org.
With two AAHRPP-accredited panels that meet weekly and on-demand Informed Consent development, Midlands IRB delivers the customized, personalized, and responsive services that its loyal clients have come to expect.
For more information, please visit www.mlirb.com.
With extensive Phase I & Single Site experience, as well as experience in Late Phase research and Post Market and Registry studies, Aspire IRB supports sponsors and contract research organizations (CROs) with hands-on, personalized service across the continuum of clinical research. Overseeing a diverse range of studies, Aspire IRB brings unmatched expertise to its review of pharmaceutical, device, biologic, nutraceutical and cosmetic research.
For more information, please visit www.aspire-irb.com.
Located in the Boston-Cambridge area, New England IRB provides a strong regional presence for high-quality, full-service, independent review. For studies ranging from one site to several thousand and spanning all phases of research, New England IRB is the definition of innovation and clinical research leadership in the Northeast corridor.
For more information, please visit www.neirb.com.
With apps to address the most common sources of frustration in the management of clinical trials, ePharmaSolutions’ award-winning ePharmaOne™ platform is widely used, hosting more than 350,000 clinical researchers in 130 countries. The industry’s only true end-to-end workflow management solution, ePharmaOne revolutionizes the quality of communication between sponsors and sites, and the efficiency with which new drugs and therapies are delivered to market.
For more information, please visit www.epharmasolutions.com.
Founded by former biopharmaceutical and CRO attorneys, Clintrax has accelerated hundreds of clinical trials since its inception. Supported by technology-driven processes and a network of international attorneys who possess specialized and in-depth knowledge of local languages and regulations across 65 countries, Clintrax significantly reduces the amount of time devoted to the negotiation process.
For more information, please visit www.clintraxglobal.com.
karmadata’s award winning technology platform enables rapid application development for applications that have big data needs. With karmadata’s APIs and the power of our linked data in the cloud, organizations can create disruptive applications at the speed of thought. karmadata’s applications are built for both data scientists and casual users, truly making big data easy.
For more information, please visit www.karmadata.com.
As a pioneer in publishing clinical trials information, CenterWatch was the first Internet site to publish detailed information on clinical trials, specific drugs, as well as other essential health and educational resources that could be accessed by patients and their advocates. Today, CenterWatch maintains one of the largest online clinical trial databases actively seeking patients. With more than 80,000 industry-funded global trials across hundreds of disease conditions and phases, the CenterWatch Clinical Trials Listing Service™ generates more than 1.8+ million unique visitors annually.
For more information, please visit www.centerwatch.com.